Literature DB >> 19015552

Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics.

Don C Des Jarlais1, Kamyar Arasteh, Holly Hagan.   

Abstract

Mesh：

Year:  2008        PMID： 19015552      PMCID： PMC2582772          DOI： 10.1503/cmaj.081678

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Sara Beatrice; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman
Journal:  Am J Public Health       Date:  2005-06-28       Impact factor: 9.308

2.  AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic.

Authors:  G V Stimson
Journal:  Soc Sci Med       Date:  1995-09       Impact factor: 4.634

3.  Harm reduction--a framework for incorporating science into drug policy.

Authors:  D C Des Jarlais
Journal:  Am J Public Health       Date:  1995-01       Impact factor: 9.308

4.  Dehumanizing the lowest of the low: neuroimaging responses to extreme out-groups.

Authors:  Lasana T Harris; Susan T Fiske
Journal:  Psychol Sci       Date:  2006-10

5.  "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Holly Hagan; Judith Milliken; Naomi Braine; Stanley Yancovitz; Donna Mildvan; David C Perlman; Carey Maslow; Samuel R Friedman
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

6.  The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions.

Authors:  Laura M Kuyper; Robert S Hogg; Julio S G Montaner; Martin T Schechter; Evan Wood
Journal:  J Urban Health       Date:  2004-12       Impact factor: 3.671

7.  The cost-effectiveness of Vancouver's supervised injection facility.

Authors:  Ahmed M Bayoumi; Gregory S Zaric
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

8.  Maintaining low HIV seroprevalence in populations of injecting drug users.

Authors:  D C Des Jarlais; H Hagan; S R Friedman; P Friedmann; D Goldberg; M Frischer; S Green; K Tunving; B Ljungberg; A Wodak
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272
  8 in total
  4 in total

1.  Negotiating the Relationship Between Addiction, Ethics, and Brain Science.

Authors:  Daniel Z Buchman; Wayne Skinner; Judy Illes
Journal:  AJOB Neurosci       Date:  2010-01

2.  Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs.

Authors:  Ehsan Jozaghi; Asheka Jackson
Journal:  Int J Health Policy Manag       Date:  2015-03-29

3.  A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada.

Authors:  Ehsan Jozaghi; Andrew A Reid; Martin A Andresen
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-07-09

4.  A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada.

Authors:  Ehsan Jozaghi; Andrew A Reid; Martin A Andresen; Alexandre Juneau
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.